Clearpoint Neuro
Stock
Stock
ISIN: US18507C1036
Ticker: CLPT
US18507C1036
CLPT
Price
Price
CHART BY
Frequently asked questions
What is Clearpoint Neuro's market capitalization?
The market capitalization of Clearpoint Neuro is $311.76M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Clearpoint Neuro?
Clearpoint Neuro's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.753. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Clearpoint Neuro's stock?
Currently, 2 analysts cover Clearpoint Neuro's stock, with a consensus target price of $29.00. Analyst ratings provide insights into the stock's expected performance.
What is Clearpoint Neuro's revenue over the trailing twelve months?
Over the trailing twelve months, Clearpoint Neuro reported a revenue of $32.24M.
What is the EBITDA for Clearpoint Neuro?
Clearpoint Neuro's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$19.92M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Clearpoint Neuro?
Clearpoint Neuro has a free cash flow of -$11.74M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Clearpoint Neuro have, and what sector and industry does it belong to?
Clearpoint Neuro employs approximately 115 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Clearpoint Neuro's shares?
The free float of Clearpoint Neuro is 24.24M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $311.76M
- EPS (TTM)
- -$0.753
- Free Float
- 24.24M
- Revenue (TTM)
- $32.24M
- EBITDA (TTM)
- -$19.92M
- Free Cashflow (TTM)
- -$11.74M
Pricing
- 52W span
- $6.25$19.22
Analyst Ratings
The price target is $29.00 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
- Employees
- 115
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US18507C1036
- Primary Ticker
- CLPT
Fundamentals & EOD data from FactSet